GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medistim ASA (OSTO:MEDIO) » Definitions » EV-to-Revenue

Medistim ASA (OSTO:MEDIO) EV-to-Revenue : 5.90 (As of Apr. 28, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Medistim ASA EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Medistim ASA's enterprise value is kr3,075.2 Mil. Medistim ASA's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was kr521.1 Mil. Therefore, Medistim ASA's EV-to-Revenue for today is 5.90.

The historical rank and industry rank for Medistim ASA's EV-to-Revenue or its related term are showing as below:

OSTO:MEDIO' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.77   Med: 5.02   Max: 18.1
Current: 5.9

During the past 13 years, the highest EV-to-Revenue of Medistim ASA was 18.10. The lowest was 1.77. And the median was 5.02.

OSTO:MEDIO's EV-to-Revenue is ranked worse than
71.32% of 823 companies
in the Medical Devices & Instruments industry
Industry Median: 3.02 vs OSTO:MEDIO: 5.90

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-28), Medistim ASA's stock price is kr171.00. Medistim ASA's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was kr28.48. Therefore, Medistim ASA's PS Ratio for today is 6.00.


Medistim ASA EV-to-Revenue Historical Data

The historical data trend for Medistim ASA's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medistim ASA EV-to-Revenue Chart

Medistim ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.71 12.71 15.79 8.41 7.26

Medistim ASA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.41 10.69 9.66 7.16 7.26

Competitive Comparison of Medistim ASA's EV-to-Revenue

For the Medical Devices subindustry, Medistim ASA's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medistim ASA's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Medistim ASA's EV-to-Revenue falls into.



Medistim ASA EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Medistim ASA's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=3075.150/521.109
=5.90

Medistim ASA's current Enterprise Value is kr3,075.2 Mil.
Medistim ASA's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr521.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medistim ASA  (OSTO:MEDIO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Medistim ASA's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=171.00/28.481
=6.00

Medistim ASA's share price for today is kr171.00.
Medistim ASA's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr28.48.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medistim ASA EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medistim ASA's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Medistim ASA (OSTO:MEDIO) Business Description

Traded in Other Exchanges
Address
Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing and sales of medical equipment through its own business or through participation in other companies, as well related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, Asia and the Rest of the World. The firm's activity is split into three strategic operating units, Lease of equipment; Lease of equipment and Distribution and sales of third-party products.

Medistim ASA (OSTO:MEDIO) Headlines

No Headlines